Intraoperative Dexamethasone and Its Effect on Hyperglycemia

Effect of Pre-Operative Dexamethasone Dose on the Post-Operative Management of Blood Sugar in Diabetic Patients

Status

Withdrawn

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03646916

Enrollment

Registered

2018-08-24

Start date

2020-09-15

Completion date

2020-12-31

Last updated

2021-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Brief summary

To study the effect of intra-operative dexamethasone on the management of post-operative blood sugar in diabetic patients.

Interventions

DRUGDexamethasone

Gluco-corticosteroid

OTHERNo dexamethasone

Nothing

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* documented history of Type I or Type II Diabetes Mellitus * scheduled for surgery that requires patients to be admitted for at least 24 hours post-surgery

Exclusion criteria

* Patients on steroid therapy * Pregnant women * Patients at low risk for nausea/vomiting

Design outcomes

Primary

Measure	Time frame
Post-operative blood sugar	24 hour Post surgery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026